Document is current
Any future updates will be listed below
-
Authors
Bey, Alexandra L.
Sabatos-DeVito, Maura
Carpenter, Kimberly L.H.
Franz, Lauren
Howard, Jill
Vermeer, Saritha
Simmons, Ryan
Troy, Jesse D.
Dawson, Geraldine https://orcid.org/0000-0003-1410-2764
-
Funding
Funding for this research was provided by:
Marcus Foundation (N/A)
- License Information
-
More Information
Article History
Accepted: 9 August 2023
First Online: 29 August 2023
Declarations
:
: Dr. Dawson is on the Scientific Advisory Boards of Akili Interactive, Inc, Zynerba, Nonverbal Learning Disability Project, and Tris Pharma, is a consultant to Apple, Gerson Lehrman Group, and Guidepoint Global, Inc., and receives book royalties from Guilford Press and Springer Nature. Dr. Dawson has stock interests in Neuvana, Inc. Dr. Dawson and Dr. Troy have developed technology, data, and/or products that have been licensed to Apple, Inc. and Cryocell, Inc. and Dawson and Duke University have benefited financially. Dr. Troy also has stock interest in NeurOp, Inc. and receives consulting fees from AegisCN, LLC. Dr. Troy also serves on Data and Safety Monitoring Boards for Synthetic Biologics, Inc. and The National Institutes of Health (NIH) and he receives honoraria from The Emmes Corporation and Navitas Clinical Research. Dr. Sabatos-DeVito consults with and received personal fees from New Frontiers. For the remaining authors none were declared.
